Agios Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update Read more about Agios Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Agios Announces Topline Results from RISE UP Phase 3 Trial of Mitapivat in Sickle Cell Disease Read more about Agios Announces Topline Results from RISE UP Phase 3 Trial of Mitapivat in Sickle Cell Disease
Agios Reports Third Quarter 2025 Financial Results and Provides Business Update Read more about Agios Reports Third Quarter 2025 Financial Results and Provides Business Update
Agios Reports Second Quarter 2025 Financial Results and Provides Business Update Read more about Agios Reports Second Quarter 2025 Financial Results and Provides Business Update
Agios Reports First Quarter 2025 Financial Results and Recent Business Highlights Read more about Agios Reports First Quarter 2025 Financial Results and Recent Business Highlights
Agios Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights Read more about Agios Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
Agios Reports Business Highlights and Third Quarter 2024 Financial Results Read more about Agios Reports Business Highlights and Third Quarter 2024 Financial Results
Agios Reports Business Highlights and Second Quarter 2024 Financial Results Read more about Agios Reports Business Highlights and Second Quarter 2024 Financial Results
Agios Announces Results from Phase 3 ACTIVATE-KidsT Study of Mitapivat in Children with PK Deficiency Who Are Regularly Transfused Read more about Agios Announces Results from Phase 3 ACTIVATE-KidsT Study of Mitapivat in Children with PK Deficiency Who Are Regularly Transfused
Agios Reports Business Highlights and First Quarter 2024 Financial Results Read more about Agios Reports Business Highlights and First Quarter 2024 Financial Results
